A Predictive Model for the Development of Hormone-Responsive Breast Cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Annals of Surgical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10434-004-1170-4PMID 15827778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acceptance of tamoxifen chemoprevention by physicians and women at risk

  2005cited by this paper
• Risk factors for breast cancer according to estrogen and progesterone receptor status.

  2004cited by this paper
• Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors.

  2004cited by this paper
• Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

  2004cited by this paper
• Steroid hormone receptors in breast cancer management

  2004cited by this paper
• A hospital-based case-control study of breast-cancer risk factors by estrogen and progesterone receptor status

  2004cited by this paper
• Acceptance of tamoxifen chemoprevention by physicians and women at risk

  2004cited by this paper
• Prevention Strategies with Aromatase Inhibitors

  2004cited by this paper
• Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.

  2003cited by this paper
• Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.

  2003cited by this paper
• Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

  2003cited by this paper
• The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age.

  2003influential reference
• Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup.

  2003influential reference
• Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status

  2003cited by this paper
• Breast cancers among very young premenopausal women (United States)

  2003cited by this paper
• Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.

  2003cited by this paper
• Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women.

  2002cited by this paper
• Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database

  2002cited by this paper
• The greater impact of menopause on ER– than ER+ breast cancer incidence: a possible explanation (United States)

  2002cited by this paper
• Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women.

  2002cited by this paper
• Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?

  2002cited by this paper
• The impact of hormone replacement therapy on the detection and stage of breast cancer.

  2002cited by this paper
• Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.

  2002cited by this paper
• Hormone Receptors in Breast Cancer: Racial Differences in Distribution and Survival

  2002cited by this paper
• Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age.

  2002cited by this paper
• Activation of muscle satellite cells in single-fiber cultures.

  2002cited by this paper
• Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan).

  2001cited by this paper
• Increased incidence of small and well‐differentiated breast tumours in post‐menopausal women following hormone‐replacement therapy

  2001cited by this paper
• Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status.

  2000influential reference
• Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.

  2000cited by this paper
• The effect of estrogen usage on the subsequent hormone receptor status of primary breast cancer

  1999cited by this paper
• The shape of age–incidence curves of female breast cancer by hormone-receptor status

  1999cited by this paper
• Reproductive risk factors for breast cancer by receptor status, histology, laterality and location

  1999cited by this paper
• Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

  1999influential reference
• Alcohol consumption and breast cancer oestrogen and progesterone receptor status

  1999influential reference
• Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

  1999cited by this paper
• Relation of smoking to breast cancer by estrogen receptor status

  1998cited by this paper
• Simulation model of mammographic calcifications based on the American College of Radiology Breast Imaging Reporting and Data System, or BIRADS.

  1998cited by this paper
• Role of differentiation in the pathogenesis and prevention of breast cancer

  1997influential reference
• Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status

  1996cited by this paper
• Hormone receptor status of breast tumors in black, Hispanic, and non‐Hispanic white women: An analysis of 13,239 cases

  1996cited by this paper
• Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?

  1995cited by this paper
• Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study.

  1995cited by this paper
• Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction

  1994cited by this paper
• Alcohol consumption and breast cancer: estrogen receptor status and histology.

  1994cited by this paper
• Estrogen Receptor Status and Dietary Intakes in Breast Cancer Patients

  1993cited by this paper
• Breast Cancer Estrogen and Progesterone Receptors: Associations with Patients' Clinical and Epidemiologic Characteristics

  1991cited by this paper
• Steroid receptor status and the epidemiology of breast cancer.

  1991cited by this paper
• Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance.

  1990cited by this paper
• Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study.

  1989cited by this paper
• Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences

  1989cited by this paper
• Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

  1989cited by this paper
• Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers.

  1986cited by this paper
• Differences in breast cancer risk factors according to the estrogen receptor level of the tumor.

  1983cited by this paper
• Clinical factors related to the presence of estrogen receptors in breast cancer: a prognostic stratification analysis.

  1982cited by this paper

• A systematic review of prediction models for risk of breast cancer

  2025cites this paper
• BREAST CANCER PREVENTION: IS IT POSSIBLE TO IMPROVE THE SELECTION BY GAIL MODEL USING THE FUZZY LOGIC METHODOLOGY? A RETROSPECTIVE STUDY

  2011cites this paper
• Arzoxifene: the development and clinical outcome of an ideal SERM

  2006cites this paper
• The impact of socio-economic factors on outcome from breast cancer

  2006cites this paper